Inflammation marker and risk of pancreatic cancer: a nested case-control study within the EPIC cohort.
about
Epidemiology and Inherited Predisposition for Sporadic Pancreatic AdenocarcinomaEarly diagnosis of pancreatic cancer: challenges and new developmentsNew insights into pancreatic cancer-induced paraneoplastic diabetesInflammation to cancer: The molecular biology in the pancreas (Review).Intraindividual variability over time in plasma biomarkers of inflammation and effects of long-term storageBody mass index, physical activity, and serum markers of inflammation, immunity, and insulin resistance.Discovering the route from inflammation to pancreatic cancer.Chronic alcohol exposure exacerbates inflammation and triggers pancreatic acinar-to-ductal metaplasia through PI3K/Akt/IKKDietary inflammatory index and risk of pancreatic cancer in an Italian case-control study.Circulating Leptin and Risk of Pancreatic Cancer: A Pooled Analysis From 3 Cohorts.Metabolic serum biomarkers for the prediction of cancer: a follow-up of the studies conducted in the Swedish AMORIS studyCytokines as Biomarkers of Pancreatic Ductal Adenocarcinoma: A Systematic Review.Metastasis Suppressors Regulate the Tumor Microenvironment by Blocking Recruitment of Prometastatic Tumor-Associated Macrophages.Inflammatory plasma markers and pancreatic cancer risk: a prospective study of five U.S. cohortsSignaling cascades of Pasteurella multocida toxin in immune evasion.Diagnostic value of selected markers and apoptotic pathways for pancreatic cancer.Serum transforming growth factor-β1 and risk of pancreatic cancer in three prospective cohort studies.Obesity and Pancreatic Cancer.Inflammatory, insulin resistance metabolic markers and pancreatic cancer: quo vadis? [corrected].
P2860
Q26801418-E47C44BD-52C1-409A-AF24-DE52955EBE2AQ27014027-91257681-F663-4BE8-A7D4-78B160137741Q27687766-7FED0E32-0A01-44FF-A0F0-8D3682047B89Q33727657-F4F0CF5F-981C-40BF-862F-44548B10F4DBQ34213725-B3C60C67-4268-4F97-AF68-FAD3E8F6B30CQ34642100-A69C2104-4A3F-4C18-B88A-1D2CB048A980Q34645978-379EA934-2B4E-4F1B-B598-1362C00D4D3DQ35040048-491DE063-2E41-436C-A9B6-FBE80ED07960Q35752298-BE70EA56-06AC-49E8-AE59-377F05102017Q35896957-5ED13E6E-046F-4AFA-B663-18D24AA9000BQ35935362-A71EF0A4-C659-417F-93AD-C65085733B32Q36015280-24F5CDD7-EAC2-4C8C-A7EE-0DE705A6ECA0Q36118028-A7EA4816-1DFA-43DA-8CD3-73CDE7C91D86Q36831927-D281ADE7-8794-4D33-BC01-C23D683C8082Q38142607-1CEDBB48-5F4C-4ED1-8849-8F029F52ACECQ38815842-D211DD25-C40F-404D-8DD3-4D4EEC56E267Q45017154-2D76857B-5D51-4852-A238-F26D208AD3F6Q50856729-2642EDA5-BB3D-4AA0-A889-89653BB9AEA7Q51217477-E4D25A3E-1A29-4D09-BD90-ACC710D175A0
P2860
Inflammation marker and risk of pancreatic cancer: a nested case-control study within the EPIC cohort.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Inflammation marker and risk o ...... study within the EPIC cohort.
@ast
Inflammation marker and risk o ...... study within the EPIC cohort.
@en
type
label
Inflammation marker and risk o ...... study within the EPIC cohort.
@ast
Inflammation marker and risk o ...... study within the EPIC cohort.
@en
prefLabel
Inflammation marker and risk o ...... study within the EPIC cohort.
@ast
Inflammation marker and risk o ...... study within the EPIC cohort.
@en
P2093
P2860
P50
P356
P1476
Inflammation marker and risk o ...... study within the EPIC cohort.
@en
P2093
A B Gurrea
A Trichopoulou
D Johansen
D S Michaud
F Clavel-Chapelon
P2860
P2888
P304
P356
10.1038/BJC.2012.172
P407
P50
P577
2012-04-26T00:00:00Z